CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion With an Engineered AAV Vector
Molecular Therapy - Nucleic Acids - United States
doi 10.1038/mtna.2016.49
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Elsevier BV